TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 177 filers reported holding TG THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $2,982,000 | -34.0% | 701,690 | +47.7% | 0.02% | -17.4% |
Q1 2022 | $4,519,000 | -48.4% | 475,190 | +5.0% | 0.02% | -39.5% |
Q4 2021 | $8,753,000 | -42.6% | 452,353 | -1.3% | 0.04% | -44.9% |
Q3 2021 | $15,247,000 | -53.2% | 458,146 | -45.4% | 0.07% | -50.7% |
Q2 2021 | $32,554,000 | -20.0% | 839,254 | +0.9% | 0.14% | -22.2% |
Q1 2021 | $40,712,000 | -42.3% | 831,547 | -38.7% | 0.18% | -54.8% |
Q4 2020 | $70,532,000 | +82.3% | 1,355,852 | -8.3% | 0.40% | +100.0% |
Q3 2020 | $38,698,000 | +44.1% | 1,478,729 | +2.3% | 0.20% | +30.1% |
Q2 2020 | $26,849,000 | – | 1,445,052 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
Antara Capital LP | 900,000 | $3,825,000 | 0.16% |